Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by SunnyGulfBeachon Apr 09, 2015 3:58pm

241 Views

Post# 23613878

RE:RE:RE:Up Over Ten Times

I wish! I was there with 15000 shares on that day when it went from 3.20 to less than .20 overnight. If I had sold the afternoon before results, my $ 45000.00 plus would have bought 225,000 shares @ .20 the best I can fighure. I did get back at .75 so I still feel ok, but not like I would have. I would expect the Ken Dart types did exactly that.......

Bullboard Posts

Rig Count Soars as Utilization Surpasses Industry Averages